The best way to use asparaginase in childhood acute lymphatic leukaemia - Still to be defined?

British Journal of Haematology

Volumn 125, Issue 2, 2004, Pages 117-127

  Boos, Joachim ^a   Pinheiro, João Paulo Vieira ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Acute lymphatic leukaemia; Asparaginase; Asparagine; Childhood; Clinical pharmacology

Indexed keywords

ASPARAGINASE; ASPARAGINASE MACROGOL; BACTERIAL ENZYME; MACROGOL; MEDAC; PARONAL;

ACUTE LYMPHOCYTIC LEUKEMIA; APOPTOSIS; BLOOD CLOTTING DISORDER; BLOOD LEVEL; BODY HEIGHT; BODY WEIGHT; CEREBROSPINAL FLUID; CHEMOTHERAPY; CHILDHOOD LEUKEMIA; CLINICAL TRIAL; COVALENT BOND; DRUG DOSE REGIMEN; DRUG ELIMINATION; DRUG EXPOSURE; DRUG MECHANISM; DRUG METABOLISM; DRUG MONITORING; DRUG USE; ENZYME ACTIVITY; ESCHERICHIA COLI; FOLLOW UP; HUMAN; HYPERSENSITIVITY REACTION; LOW DRUG DOSE; LYMPHOBLASTOID CELL; MOLECULAR WEIGHT; MOLECULE; NONHUMAN; PRIORITY JOURNAL; REMISSION; RETICULAR FORMATION; REVIEW; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; SURVIVAL RATE;

ANTINEOPLASTIC AGENTS; ASPARAGINASE; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

EID: 2042503031     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.04863.x     Document Type: Review

References (69)

1. Abshire, T.C., Pollock, B.H., Billett, A.L., Bradley, P. & Buchanan, G.R. (2000) Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: a Pediatric Oncology Group Study. Blood, 96, 1709-1715.
2. Ahlke, E., Nowak-Göttl, U., Schulze-Westhoff, P., Werber, G., Börste, H., Würthwein, G., Jürgens, H. & Boos, J. (1997) Dose reduction of asparaginase under pharmacokinetic and pharmacodynamic control during induction therapy in children with acute lymphoblastic leukaemia. British Journal of Haematology, 96, 675-681.
3. Albertsen, B.K., Jakobsen, P., Schroder, H., Schmiegelow, K. & Carlsen, N.T. (2001a) Pharmacokinetics of Erwinia asparaginase after intravenous and intramuscular administration. Cancer Chemotherapy and Pharmacology, 48, 77-82.
4. Albertsen, B.K., Schroder, H., Jakobsen, P., Müller, H.J., Carlsen, N.T. & Schmiegelow, K. (2001b) Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries. British Journal of Clinical Pharmacology, 52, 433-437.
5. Albertsen, B.K., Schroder, H., Jakobsen, P., Avramis, V.I., Müller, H.J., Schmiegelow, K. & Carlsen, N.T. (2002) Antibody formation during intravenous and intramuscular therapy with Erwinia asparaginase. Medical and Pediatric Oncology, 38, 310-316.
6. Appel, I.M., Pinheiro, J.P., Den Boer, M.L., Lanvers, C., Reniers, N.C., Boos, J. & Pieters, R. (2003) Lack of asparagine depletion in the cerebrospinal fluid after one intravenous dose of PEG-asparaginase: a window study at initial diagnosis of childhood ALL. Leukemia, 17, 2254-2256.
7. Asselin, B.L. (1999) The three asparaginases. Comparative pharmacology and optimal use in childhood leukemia. Advances in Experimental Medicine and Biology, 457, 621-629.
8. Asselin, B.L., Whitin, J.C., Coppola, D.J., Rupp, I.P., Sallan, S.E. & Cohen, H.J. (1993) Comparative pharmacokinetic studies of three asparaginase preparations. Journal of Clinical Oncology, 11, 1780-1786.
9. Avramis, V.I. & Holcenberg, J.S. (2002) PEG-asparaginase and deamination of serum asparagine in children with standard-risk lymphoblastic leukemia (CCG-1962) [author reply]. Blood, 100, 1924-1925.
10. Avramis, V.I., Sencer, S., Periclou, A.P., Sather, H., Bostrom, B.C., Cohen, L.J., Ettinger, A.G., Ettinger, L.J., Franklin, J., Gaynon, P.S., Hilden, J.M., Lange, B., Majlessipour, F., Mathew, P., Needle, M., Neglia, J., Reaman, G., Holcenberg, J.S. & Stork, L. (2002) A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study. Blood, 99, 1986-1994. Erratum in: Blood, 2002, 100, 1531.
11. Becker, F.F. & Broome, J.D. (1967) L-asparaginase: inhibition of early mitosis in regenerating rat liver. Science, 156, 1602-1603.
12. Becker, F.F. & Broome, J.D. (1969) L-asparaginase: inhibition of endogenous RNA polymerase activity in regenerating liver. Archives of Biochemistry and Biophysics, 130, 332-336.
13. Berg, S.L., Balis, F.M., McCully, C.L., Godwin, K.S. & Poplack, D.G. (1993) Pharmacokinetics of PEG-L-asparaginase and plasma and cerebrospinal fluid L-asparagine concentrations in the rhesus monkey. Cancer Chemotherapy and Pharmacology, 32, 310-314.
14. Billett, A.L., Carls, A., Gelber, R.D. & Sallan, S.E. (1992) Allergic reactions to Erwinia asparaginase in children with acute lymphoblastic leukemia who had previous allergic reactions to Escherichia coli asparaginase. Cancer, 70, 201-206.
15. Boos, J., Werber, G., Ahlke, E., Schulze-Westhoff, P., Nowak-Göttl, U., Würthwein, G., Verspohl, E.J., Ritter, J. & Jürgens, H. (1996) Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations. European Journal of Cancer, 32A, 1544-1550.
16. Brueck, M., Koerholz, D., Nuernberger, W., Juergens, H., Goebel, U. & Wahn, V. (1989) Elimination of L-asparaginase in children treated for acute lymphoblastic leukemia. Developmental Pharmacology and Therapeutics, 12, 200-204.
17. Cooney, D.A. & Handschumacher, R.E. (1970) L-asparaginase and L-asparagine metabolism. Annual Review of Pharmacology, 10, 421-440.
18. Duval, M., Suciu, S., Ferster, A., Rialland, X., Nelken, B., Lutz, P., Benoit, Y., Robert, A., Manel, A.M., Vilmer, E., Otten, J. & Philippe, N. (2002) Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial. Blood, 99, 2734-2739.
19. Eden, O.B., Harrison, G., Richards, S., Lilleyman, J.S., Bailey, C.C., Chessells, J.M., Hann, I.M., Hill, F.G. & Gibson, B.E. (2000) Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997. Medical Research Council Childhood Leukaemia Working Party. Leukemia, 14, 2307-2320.
20. Ertel, I.J., Nesbit, M.E., Hammond, D., Weiner, J. & Sather, H. (1979) Effective dose of L-asparaginase for induction of remission in previously treated children with acute lymphocytic leukemia: a report from Children's Cancer Study Group. Cancer Research, 39, 3893-3896.
21. Ettinger, L.J., Kurtzberg, J., Voute, P.A., Jürgens, H. & Halpern, S.L. (1995) An open-label, multicenter study of polyethylene glycol-L-asparaginase for the treatment of acute lymphoblastic leukemia. Cancer, 75, 1176-1181.
22. Evans, W.E., Tsiatis, A., Rivera, G., Murphy, S.B., Dahl, G.V., Denison, M., Crom, W.R., Barker, L.F. & Mauer, A.M. (1982) Anaphylactoid reactions to Escherichia coli and Erwinia asparaginase in children with leukemia and lymphoma. Cancer, 49, 1378-1383.
23. Gaynon, P.S., Trigg, M.E., Heerema, N.A., Sensel, M.G., Sather, H.N., Hammond, G.D. & Bleyer, W.A. (2000) Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995. Leukemia, 14, 2223-2233.
24. Gentili, D., Conter, V., Rizzari, C., Tschuemperlin, B., Zucchetti, M., Orlandoni, D., D'Incalci, M. & Masera, G. (1996) L-asparagine depletion in plasma and cerebro-spinal fluid of children with acute lymphoblastic leukemia during subsequent exposures to Erwinia L-asparaginase. Annals of Oncology, 7, 725-730.
25. Gerrits, G.P., Trijbels, F.J., Monnens, L.A., Gabreels, F.J., De Abreu, R.A., Theeuwes, A.G. & van Raay-Selten, B. (1989) Reference values for amino acids in cerebrospinal fluid of children determined using ion-exchange chromatography with fluorimetric detection. Clinica Chimica Acta, 182, 271-280.
26. Haley, E.E., Fischer, G.A. & Welch, A.D. (1961) The requirement for L-asparagine of mouse leukemia cells L5178Y in culture. Cancer Research, 21, 532-536.
27. Harris, J.M. & Chess, R.B. (2003) Effect of pegylation on pharmaceuticals. Nature Reviews. Drug Discovery, 2, 214-221.
28. Ho, D.H., Brown, N.S., Yen, A., Holmes, R., Keating, M., Abuchowski, A., Newman, R.A. & Krakoff, I.H. (1986) Clinical pharmacology of polyethylene glycol-L-asparaginase. Drug Metabolism and Disposition, 14, 349-352.
29. Holle, L.M. (1997) Pegaspargase: an alternative? Annals of Pharmacotherapy, 31, 616-624.
30. Jaffe, N., Traggis, D., Das, L., Moloney, W.C., Hann, H.W., Kim, B.S. & Nair, R. (1971) L-asparaginase in the treatment of neoplastic diseases in children. Cancer Research, 31, 942-949.
31. Kamisaki, Y., Wada, H., Yagura, T., Matsushima, A. & Inada, Y. (1981) Reduction in immunogenicity and clearance rate of Escherichia coli L-asparaginase by modification with monomethoxypolyethylene glycol. Journal of Pharmacology and Experimental Therapeutics, 216, 410-414.
32. Keating, M.J., Holmes, R., Lerner, S. & Ho, D.H. (1993) L-asparaginase and PEG asparaginase - past, present, and future. Leukemia and Lymphoma, 10(Suppl.), 153-157.
33. Killander, D., Dohlwitz, A., Engstedt, L., Franzen, S., Gahrton, G., Gullbring, B., Holm, G., Holmgren, A., Hoglund, S., Killander, A., Lockner, D., Mellstedt, H., Moe, P.J., Palmblad, J., Reizenstein, P., Skarberg, K.O., Swedberg, B., Uden, A.M., Wadman, B., Wide, L. & Ahstrom, L. (1976) Hypersensitive reactions and antibody formation during L-asparaginase treatment of children and adults with acute leukemia. Cancer, 37, 220-228.
34. Kurtzberg, J. (1994) A new look at PEG-L-asparaginase and other asparaginases in hematological malignancies. Cancer Investigation, 12(Suppl. 1), 59-60.
35. Kurtzberg, J., Asselin, B., Poplack, D., Grebanier, A., Chen, R., Franklin, A., Scudiery, D. & Fisherman, J. (1993) Antibodies to asparaginase alter pharmacokinetics and decrease enzyme activity in patients on asparaginase therapy. Proceedings of the American Association for Cancer Research, 34, 304.
36. Lanvers, C., Vieira Pinheiro, J.P., Hempel, G., Wuerthwein, G. & Boos, J. (2002) Analytical validation of a microplate reader-based method for the therapeutic drug monitoring of L-asparaginase in human serum. Analytical Biochemistry, 309, 117-126.
37. Lepage, N., McDonald, N., Dallaire, L. & Lambert, M. (1997) Age-specific distribution of plasma amino acid concentrations in a healthy pediatric population. Clinical Chemistry, 43, 2397-2402.
38. Mashburn, L.T. & Wriston, J.C. (1964) Tumor inhibitory effect from Escherichia coli. Archives of Biochemistry and Biophysics, 105, 450-452.
39. Müller, H.J. & Boos, J. (1998) Use of L-asparaginase in childhood ALL. Critical Reviews in Oncology and Hematology, 28, 97-113.
40. Müller, H.J., Loning, L., Horn, A., Schwabe, D., Gunkel, M., Schrappe, M., von Schutz, V., Henze, G., Casimiro da Palma, J., Ritter, J., Pinheiro, J.P., Winkelhorst, M. & Boos, J. (2000) Pegylated asparaginase (Oncaspar) in children with ALL: drug monitoring in reinduction according to the ALL/NHL-BFM 95 protocols. British Journal of Haematology, 110, 379-384.
41. Müller, H.J., Beier, R., Loning, L., Blutters-Sawatzki, R., Dorffel, W., Maass, E., Muller-Weihrich, S., Scheel-Walter, H.G., Scherer, F., Stahnke, K., Schrappe, M., Horn, A., Lumkemann, K. & Boos, J. (2001) Pharmacokinetics of native Escherichia coli asparaginase (Asparaginase medac) and hypersensitivity reactions in ALL-BFM 95 reinduction treatment. British Journal of Haematology, 114, 794-799.
42. Müller, H.J., Beier, R., da Palma, J.C., Lanvers, C., Ahlke, E., von Schutz, V., Gunkel, M., Horn, A., Schrappe, M., Henze, G., Kranz, K. & Boos, J. (2002) PEG-asparaginase (Oncaspar) 2500 U/m(2) BSA in reinduction and relapse treatment in the ALL/NHL-BFM protocols. Cancer Chemotherapy and Pharmacology, 49, 149-154.
43. Nesbit, M., Chard, R., Evans, A., Karon, M. & Hammond, G.D. (1979) Evaluation of intramuscular versus intravenous administration of L-asparaginase in childhood leukemia. American Journal of Pediatric Hematology and Oncology, 1, 9-13.
44. Nesbit, M.E., Ertel, I. & Hammond, G.D. (1981) L-asparaginase as a single agent in acute lymphocytic leukemia: survey of studies form Children's Cancer Study Group. Cancer Treatment Reports, 65(Suppl. 4), 101-107.
45. Oettgen, H.F., Old, L.J., Boyse, E.A., Campbell, H.A., Philips, F.S., Clarkson, B.D., Tallal, L., Leeper, R.D., Schwartz, M.K. & Kim, J.H. (1967) Inhibition of leukemias in man by L-asparaginase. Cancer Research, 27, 2619-2631.
46. Ohnuma, T., Holland, J.F., Freeman, A. & Sinks, L.F. (1970) Biochemical and pharmacological studies with asparaginase in man. Cancer Research, 30, 2297-2305.
47. Ohnuma, T., Holland, J.F. & Meyer, P. (1972) Erwinia carotovora asparaginase in patients with prior anaphylaxis to asparaginase from E. coli. Cancer, 30, 376-381.
48. Park, Y.K., Abuchowski, A., Davis, S. & Davis, F. (1981) Pharmacology of Escherichia coli-L-asparaginase polyethylene glycol adduct. Anticancer Research, 1, 373-376.
49. Prager, M.D. & Bachynsky, N. (1968) Asparagine synthetase in normal and malignant tissues: correlation with tumor sensitivity to asparaginase. Archives of Biochemistry and Biophysics, 127, 645-654.
50. Riccardi, R., Holcenberg, J.S., Glaubiger, D.L., Wood, J.H. & Poplack, D.G. (1981) L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans. Cancer Research, 41(Pt 1), 4554-4558.
51. Rizzari, C., Zucchetti, M., Conter, V., Diomede, L., Bruno, A., Gavazzi, L., Paganini, M., Sparano, P., Lo Nigro, L., Arico, M., Milani, M. & D'Incalci, M. (2000) L-asparagine depletion and L-asparaginase activity in children with acute lymphoblastic leukemia receiving i.m. or i.v. Erwinia C. or E. coli L-asparaginase as first exposure. Annals of Oncology, 11, 189-193.
52. Schellekens, H. (2002) Immunogenicity of therapeutic proteins: clinical implications and future prospects. Clinical Therapeutics, 24, 1720-1740.
53. Schrappe, M., Reiter, A., Zimmermann, M., Harbott, J., Ludwig, W.D., Henze, G., Gadner, H., Odenwald, E. & Riehm, H. (2000) Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Munster. Leukemia, 14, 2205-2222.
54. Schwartz, M.K., Lash, E.D., Oettgen, H.F. & Tomato, F.A. (1970) L-asparaginase activity in plasma and other biological fluids. Cancer, 25, 244-252.
55. Silverman, L.B., Gelber, R.D., Dalten, V.K., Asselin, B.L., Barr, R.D., Clavell, L.A., Hurwitz, C.A., Moghrabi, A., Samson, Y., Schorin, M.A., Arkin, S., Declerck, L., Cohen, H.J. & Sallan, S.E. (2001) Improved outcome for children with acute lymphoblastic leukaemia: results of Dana-Farber Consortium Protocol 91-01. Blood, 97, 1211-1218.
56. Story, M.D., Voehringer, D.W., Stephens, L.C. & Meyn, R.E. (1993) L-asparaginase kills lymphoma cells by apoptosis. Cancer Chemotherapy and Pharmacology, 32, 129-133.
57. Sutow, W.W., Garcia, F., Starling, K.A., Williams, T.E., Lane, D.M. & Gehan, E.A. (1971) L-asparaginase therapy in children with advanced leukemia. The Southwest Cancer Chemotherapy Study Group. Cancer, 28, 819-824.
58. Tallal, L., Tan, C., Oettgen, H., Wollner, N., McCarthy, M., Helson, L., Burchenal, J., Karnofsky, D. & Murphy, M.L. (1970) E. coli L-asparaginase in the treatment of leukemia and solid tumors in 131 children. Cancer, 25, 306-320.
59. Ueno, T., Ohtawa, K., Mitsui, K., Kodera, Y., Hiroto, M., Matsushima, A., Inada, Y. & Nishimura, H. (1997) Cell cycle arrest and apoptosis of leukemia cells induced by L-asparaginase. Leukemia, 11, 1858-1861.
60. Vieira Pinheiro, J.P., Ahlke, E., Nowak-Göttl, U., Hempel, G., Müller, H.J., Lümkemann, K., Schrappe, M., Rath, B., Fleischhack, G., Mann, G. & Boos, J. (1999) Pharmacokinetic dose adjustment of Erwinia asparaginase in protocol II of the paediatric ALL/NHL-BFM treatment protocols. British Journal of Haematology, 104, 313-320.
61. Vieira Pinheiro, J.P., Müller, H.J., Schwabe, D., Gunkel, M., Casimiro da Palma, J., Henze, G., von Schütz, V., Winkelhorst, M., Würthwein, G. & Boos, J. (2001) Drug monitoring of low-dose PEG-asparaginase (Oncaspar) in children with relapsed acute lymphoblastic leukaemia. British Journal of Haematology, 113, 115-119.
62. Vieira Pinheiro, J.P., Lanvers, C., Würthwein, G., Beier, R., Casimiro da Palma, J., von Stackelberg, A. & Boos, J. (2002) Drug monitoring of PEG-asparaginase treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma. Leukemia and Lymphoma, 43, 1911-1920.
63. Vilmer, E., Suciu, S., Ferster, A., Bertrand, Y., Cave, H., Thyss, A., Benoit, Y., Dastugue, N., Fournier, M., Souillet, G., Manel, A.M., Robert, A., Nelken, B., Millot, F., Lutz, P., Rialland, X., Mechinaud, F., Boutard, P., Behar, C., Chantraine, J.M., Plouvier, E., Laureys, G., Brock, P., Uyttebroeck, A., Margueritte, G., Plantaz, D., Norton, L., Francotte, N., Gyselinck, J., Waterkeyn, C., Solbu, G., Philippe, N. & Otten, J. (2000) Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative Group. Leukemia, 14, 2257-2266.
64. Wade, H.E., Elsworth, R., Herbert, E., Keppie, J. & Sargeant, K. (1968) A new L-asparaginase with antitumor activity? Lancet, 2, 776-777.
65. Wang, B., Hak, L.J., Relling, M.V., Pui, C.H., Woo, M.H. & Storm, M.C. (2000) ELISA to evaluate plasma anti-asparaginase IgG concentrations in patients with acute lymphoblastic leukemia. Journal of Immunological Methods, 239, 75-83.
66. Wang, B., Relling, M.V., Storm, M.C., Woo, M.H., Ribeiro, R., Pui, C.H. & Hak, L.J. (2003) Evaluation of immunologic crossreaction of antiasparaginase antibodies in acute lymphoblastic leukemia (ALL) and lymphoma patients. Leukemia, 17, 1583-1588.
67. Woo, M.H., Hak, L.J., Storm, M.C., Evans, W.E., Sandlund, J.T., Rivera, G.K., Wang, B., Pui, C.H. & Relling, M.V. (1998) Antiasparaginase antibodies following E. coli asparaginase therapy in pediatric acute lymphoblastic leukemia. Leukemia, 12, 1527-1533.
68. Woo, M.H., Hak, L.J., Storm, M.C., Gajjar, A.J., Sandlund, J.T., Harrison, P.L., Wang, B., Pui, C.H. & Relling, M.V. (1999) Cerebrospinal fluid asparagine concentrations after Escherichia coli asparaginase in children with acute lymphoblastic leukemia. Journal of Clinical Oncology, 17, 1568-1573.
69. Wriston, J.C. & Yellin, T.O. (1973) L-asparaginase: a review. Advances in Enzymology and Related Areas of Molecular Biology, 39, 185-248.